Advancing Scientific Innovation.
Transforming Metabolic Medicine.
For more than 15 years, Islet Sciences has been advancing scientific innovation across metabolic disease, drug delivery technologies, and therapeutic development. Our mission is to translate groundbreaking research into technologies that improve patient outcomes and shape the future of precision medicine.
Our Story
Islet Sciences was founded on a simple conviction: the most meaningful advances in medicine come from disciplined science applied to problems that matter. For more than fifteen years, we have advanced research, developed novel intellectual property, and built a pharmaceutical platform focused on metabolic disease, precision therapeutics, and next-generation drug delivery.
Our work is grounded in a single commitment — moving discoveries from the laboratory into real-world clinical applications that improve patient outcomes.
- 12008
Founded on a scientific premise
Islet Sciences is established to translate metabolic disease research into differentiated pharmaceutical technologies.
- 22012
Molecular laboratory established
A high-complexity molecular laboratory is built in St. Augustine, Florida — anchoring the company's translational capabilities.
- 32017
Biphasic delivery platform conceived
Research programs converge on a controlled biphasic drug delivery architecture designed to improve PK across multiple therapeutic classes.
- 42021
Platform patent issued (US 10,940,159 B2)
The biphasic delivery platform is granted, anchoring a portfolio of differentiated metabolic and combination assets.
- 5Today
Commercializing a multi-asset platform
Islet Sciences advances licensing, partnership, and co-development opportunities across GLP-1, SGLT2, and combination therapies.
High-Complexity Molecular Laboratory
Islet Sciences operates from its high-complexity molecular laboratory in St. Augustine, Florida, where multidisciplinary scientists, researchers, and technical experts work side by side to advance innovative diagnostic and therapeutic technologies.
The laboratory anchors our translational science capabilities — connecting molecular biology, biomarker discovery, and assay development with the pharmaceutical programs advancing across our platform.
Our Mission
To accelerate the development and commercialization of transformative diagnostic and therapeutic technologies that enable earlier intervention, improve patient outcomes, and advance the future of precision medicine through scientific excellence and innovation.
Our Vision
To become a global leader in metabolic innovation by developing technologies that redefine disease detection, therapeutic delivery, and personalized medicine — empowering researchers, pharmaceutical partners, clinicians, and healthcare systems to improve lives through science.
Scientific Leadership
Islet Sciences brings together a multidisciplinary team of experienced scientists, researchers, clinicians, and biotechnology professionals — internationally experienced and deeply committed to scientific excellence.
Our culture is built on scientific rigor, innovation, and collaboration, with long-standing expertise across metabolic disease research, pharmaceutical sciences, molecular diagnostics, and translational medicine.
Scientific Rigor
Every program is grounded in peer-reviewed science, mechanistic logic, and reproducible experimentation.
Translational Focus
We work where discovery meets clinical reality — bridging the gap from research bench to patient impact.
Long-Horizon Vision
We build platforms, not single assets — designed to compound value across multiple therapeutic categories.